Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 154

1.

Ebola virus uses clathrin-mediated endocytosis as an entry pathway.

Bhattacharyya S, Warfield KL, Ruthel G, Bavari S, Aman MJ, Hope TJ.

Virology. 2010 May 25;401(1):18-28. doi: 10.1016/j.virol.2010.02.015. Epub 2010 Mar 3.

2.

Ebolavirus is internalized into host cells via macropinocytosis in a viral glycoprotein-dependent manner.

Nanbo A, Imai M, Watanabe S, Noda T, Takahashi K, Neumann G, Halfmann P, Kawaoka Y.

PLoS Pathog. 2010 Sep 23;6(9):e1001121. doi: 10.1371/journal.ppat.1001121.

3.

Differential requirements for clathrin endocytic pathway components in cellular entry by Ebola and Marburg glycoprotein pseudovirions.

Bhattacharyya S, Hope TJ, Young JA.

Virology. 2011 Oct 10;419(1):1-9. doi: 10.1016/j.virol.2011.07.018. Epub 2011 Aug 19.

4.

Identification of entry inhibitors of Ebola virus pseudotyped vectors from a myxobacterial compound library.

Beck S, Henß L, Weidner T, Herrmann J, Müller R, Chao YK, Grimm C, Weber C, Sliva K, Schnierle BS.

Antiviral Res. 2016 Aug;132:85-91. doi: 10.1016/j.antiviral.2016.05.017. Epub 2016 May 27.

PMID:
27241689
5.

Characterization of the inhibitory effect of an extract of Prunella vulgaris on Ebola virus glycoprotein (GP)-mediated virus entry and infection.

Zhang X, Ao Z, Bello A, Ran X, Liu S, Wigle J, Kobinger G, Yao X.

Antiviral Res. 2016 Mar;127:20-31. doi: 10.1016/j.antiviral.2016.01.001. Epub 2016 Jan 9.

PMID:
26778707
6.
7.

Ebola virus enters host cells by macropinocytosis and clathrin-mediated endocytosis.

Aleksandrowicz P, Marzi A, Biedenkopf N, Beimforde N, Becker S, Hoenen T, Feldmann H, Schnittler HJ.

J Infect Dis. 2011 Nov;204 Suppl 3:S957-67. doi: 10.1093/infdis/jir326.

8.

Statins Suppress Ebola Virus Infectivity by Interfering with Glycoprotein Processing.

Shrivastava-Ranjan P, Flint M, Bergeron É, McElroy AK, Chatterjee P, Albariño CG, Nichol ST, Spiropoulou CF.

MBio. 2018 May 1;9(3). pii: e00660-18. doi: 10.1128/mBio.00660-18.

9.

Novel Small Molecule Entry Inhibitors of Ebola Virus.

Basu A, Mills DM, Mitchell D, Ndungo E, Williams JD, Herbert AS, Dye JM, Moir DT, Chandran K, Patterson JL, Rong L, Bowlin TL.

J Infect Dis. 2015 Oct 1;212 Suppl 2:S425-34. doi: 10.1093/infdis/jiv223. Epub 2015 Jul 22.

10.

Cellular entry of ebola virus involves uptake by a macropinocytosis-like mechanism and subsequent trafficking through early and late endosomes.

Saeed MF, Kolokoltsov AA, Albrecht T, Davey RA.

PLoS Pathog. 2010 Sep 16;6(9):e1001110. doi: 10.1371/journal.ppat.1001110.

11.

Rho GTPases modulate entry of Ebola virus and vesicular stomatitis virus pseudotyped vectors.

Quinn K, Brindley MA, Weller ML, Kaludov N, Kondratowicz A, Hunt CL, Sinn PL, McCray PB Jr, Stein CS, Davidson BL, Flick R, Mandell R, Staplin W, Maury W, Chiorini JA.

J Virol. 2009 Oct;83(19):10176-86. doi: 10.1128/JVI.00422-09. Epub 2009 Jul 22.

12.

Cell-cell contact promotes Ebola virus GP-mediated infection.

Miao C, Li M, Zheng YM, Cohen FS, Liu SL.

Virology. 2016 Jan 15;488:202-15. doi: 10.1016/j.virol.2015.11.019. Epub 2015 Dec 3.

14.

Multiple cationic amphiphiles induce a Niemann-Pick C phenotype and inhibit Ebola virus entry and infection.

Shoemaker CJ, Schornberg KL, Delos SE, Scully C, Pajouhesh H, Olinger GG, Johansen LM, White JM.

PLoS One. 2013;8(2):e56265. doi: 10.1371/journal.pone.0056265. Epub 2013 Feb 18. Erratum in: PLoS One. 2013;8(10). doi:10.1371/annotation/76780c06-ac81-48a3-8cce-509da6858fe5.

15.

Entry of a novel marine DNA virus, Singapore grouper iridovirus, into host cells occurs via clathrin-mediated endocytosis and macropinocytosis in a pH-dependent manner.

Wang S, Huang X, Huang Y, Hao X, Xu H, Cai M, Wang H, Qin Q.

J Virol. 2014 Nov;88(22):13047-63. doi: 10.1128/JVI.01744-14. Epub 2014 Aug 27.

16.

Hepatitis C virus entry depends on clathrin-mediated endocytosis.

Blanchard E, Belouzard S, Goueslain L, Wakita T, Dubuisson J, Wychowski C, Rouillé Y.

J Virol. 2006 Jul;80(14):6964-72.

17.

Cathepsin B & L are not required for ebola virus replication.

Marzi A, Reinheckel T, Feldmann H.

PLoS Negl Trop Dis. 2012;6(12):e1923. doi: 10.1371/journal.pntd.0001923. Epub 2012 Dec 6.

18.

Growth-Adaptive Mutations in the Ebola Virus Makona Glycoprotein Alter Different Steps in the Virus Entry Pathway.

Ruedas JB, Arnold CE, Palacios G, Connor JH.

J Virol. 2018 Sep 12;92(19). pii: e00820-18. doi: 10.1128/JVI.00820-18. Print 2018 Oct 1.

PMID:
30021890
19.

Suramin is a potent inhibitor of Chikungunya and Ebola virus cell entry.

Henß L, Beck S, Weidner T, Biedenkopf N, Sliva K, Weber C, Becker S, Schnierle BS.

Virol J. 2016 Aug 31;13:149. doi: 10.1186/s12985-016-0607-2.

20.

[Research progress on ebola virus glycoprotein].

Ding GY, Wang ZY, Gao L, Jiang BF.

Bing Du Xue Bao. 2013 Mar;29(2):233-7. Review. Chinese.

PMID:
23757858

Supplemental Content

Support Center